-
Study indicates lockdown significantly reduced coronavirus
pharmatimes
July 15, 2020
The largest study to date examining rates of coronavirus infection in the general public has found that there was a significant reduction of the virus before lockdown restrictions were eased.
-
Drug linked to 45% lower risk of dying among COVID-19 patients on ventilators
worldpharmanews
July 15, 2020
Critically ill COVID-19 patients who received a single dose of a drug that calms an overreacting immune system were 45% less likely to die overall, and more likely to be out of the hospital or off a ventilator one month after treatment ...
-
Charity warns of 'catastrophic' effect of COVID-19 on stroke research
pharmatimes
July 14, 2020
The Stroke Association says it has been forced to suspend three-quarters of its funded research projects because of the coronavirus pandemic, which has devastated its fund-raising capabilities.
-
Scientists focus on how immune system T cells fight coronavirus in absence of antibodies
expresspharma
July 13, 2020
Recent studies show that some recovered patients who tested negative for coronavirus antibodies did develop T cells in response to their COVID-19 infection.
-
Pandemic exposes scientific rift over proving when germs are airborne
expresspharma
July 13, 2020
The WHO acknowledged this week that the novel coronavirus can spread through tiny droplets floating in the air, a nod to more than 200 experts in aerosol science.
-
Coronavirus tricks the body into attacking brain; common heartburn drugs linked to coronavirus risk
expresspharma
July 10, 2020
Widely used heartburn drugs that have been linked with numerous complications including higher risk for kidney disease and dementia with long-term use may also be tied to a higher risk for COVID-19.
-
UK scientists plead with PM for charity partnership fund
pharmatimes
July 09, 2020
The UK's medical research charities are calling for urgent financial support following decimation of research income amid the coronavirus pandemic.
-
WHO reviewing report urging new guidance over airborne spread of coronavirus
expresspharma
July 08, 2020
How frequently the coronavirus can spread by the airborne or aerosol route - as opposed to by larger droplets in coughs and sneezes - is not clear.
-
Hundreds of scientists say coronavirus is airborne, ask WHO to revise recommendations: NYT
expresspharma
July 07, 2020
The WHO has said the coronavirus disease spreads primarily from person to person through small droplets from the nose or mouth.
-
US FDA releases guidance for approval of COVID-19 vaccines
expresspharma
July 02, 2020
The US Food and Drug Administration has released guidance to approve a coronavirus vaccine. It highlights that the vaccine has to prevent or decrease disease severity in at least 50 per cent of people who are inoculated.